People · Operator
Named in public records as an officer, director or promoter · active 2010–2015 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cognition Therapeutics Inc | — | Biotechnology | Series B | $34.9M | $65.4M | 2010 |
| QR Pharma, Inc. | — | Pharmaceuticals | Seed | $5.1M | $9.6M | 2013 |
Franz F. Hefti at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Franz F. Hefti on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Franz Hefti | 2 | 6 |
| Michael Hoffman | 1 | 11 |
| Paul Blake | 1 | 10 |
| Aaron Fletcher | 1 | 5 |
| Robert Gailus | 1 | 4 |
| Claudine Bruck | 1 | 3 |
| Irwin Scher | 1 | 2 |
| Kenneth I. Moch | 1 | 2 |
| Barbara S. Schilberg | 1 | 2 |
| Mark White | 1 | 2 |
| Peggy Wallace | 1 | 2 |
| Franz T. Hefti | 1 | 1 |
| Nada T. Jain | 1 | 1 |
| Harold Safferstein | 1 | 1 |
| Mark T. Breedlove | 1 | 1 |
| Mark F. Breedlove | 1 | 1 |
| Hal S. Broderson | 1 | 1 |
| Nada F. Jain | 1 | 1 |
| Nada Jain | 1 | 1 |
| Mark Breedlove | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.